Get the Stockscreener App
1.38
4.17%
-0.06
After Hours:
1.35
-0.03
-2.17%
Tscan Therapeutics Inc Stock (TCRX) Forecast
The Tscan Therapeutics Inc (TCRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.214, representing a +205.36% increase from the current price of $1.38. The highest analyst price target is $5.0042, and the lowest is $3.4238.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TCRX Price Target
Average 4.4961
(+225.80% Upside)
Is Tscan Therapeutics Inc (TCRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.25 | Neutral |
| STOCH(9,6) | 40.62 | Neutral |
| STOCHRSI(14) | 77.21 | Neutral |
| MACD(12,26) | -0.0437 | Buy |
| ADX(14) | 24.99 | Neutral |
| William %R | -35.29 | Neutral |
| CCI(14) | 31.00 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.312
Buy
|
1.3403
Buy
|
| MA20 |
1.3968
Sell
|
1.3683
Buy
|
| MA50 |
1.4132
Sell
|
1.5321
Sell
|
| MA100 |
1.8793
Sell
|
2.0656
Sell
|
| MA200 |
3.4256
Sell
|
3.229
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, TCRX could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 7 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on TCRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 49.25 indicates that TCRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 40.62 indicates that TCRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 77.21 indicates that TCRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.99 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 31 indicates that TCRX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TCRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Tscan Therapeutics Inc financial reports and earnings history, Tscan Therapeutics Inc (TCRX) stock could reach $7.7587 by 2030, $7.3728 by 2040 and $10.08 by 2050. See the projected annual prices until 2050 of the Tscan Therapeutics Inc stock below:
- Tscan Therapeutics Inc (TCRX) is expected to reach an average price of $5.7288 in 2035, with a high prediction of $6.4321 and a low estimate of $5.5688. This indicates an $315.13% rise from the last recorded price of $1.38.
- Tscan Therapeutics Inc (TCRX) stock is projected to chart a bullish course in 2040, with an average price target of $6.8578, representing an $396.94% surge from its current level. The forecast ranges from a conservative $6.7011 to a sky-high $7.3728.
- Our analysts predict Tscan Therapeutics Inc (TCRX) to jump 658.45% by 2045, soaring from $10.09 to an average price of $10.47, potentially reaching $11.62. While $10.09 is the low estimate, the potential upside is significant.
- Tscan Therapeutics Inc (TCRX) stock is expected to climb by 2050, reaching an average of $9.7535, a $606.78% jump from its current level. However, a wide range of estimates exists, with high and low targets of $10.08 and $8.4776, respectively, highlighting the market's uncertainty.
Tscan Therapeutics Inc Stock (TCRX) Year by Year Forecast
Tscan Therapeutics Inc Stock (TCRX) Price Forecast for 2025
Tscan Therapeutics Inc Stock (TCRX) is expected to reach an average price of $3.7515 in 2025, with a high prediction of $5.3013 and a low estimate of $2.2018. This indicates an +171.85% rise from the last recorded price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $3.6647 | $3.4238 | $5.0042 | +165.56% |
| July, 2025 | $3.6267 | $3.3651 | $4.3967 | +162.81% |
| August, 2025 | $3.5084 | $3.2484 | $4.0572 | +154.23% |
| September, 2025 | $3.0084 | $2.8197 | $3.6387 | +118.00% |
| October, 2025 | $2.6422 | $2.2018 | $3.1905 | +91.46% |
| November, 2025 | $2.5739 | $2.4026 | $3.4234 | +86.51% |
| December, 2025 | $3.7059 | $2.4401 | $4.0355 | +168.55% |
Tscan Therapeutics Inc Stock (TCRX) Price Forecast for 2026
The predicted value for Tscan Therapeutics Inc (TCRX) in 2026 is set at an average of $5.1522. Estimates vary from a peak of $7.9243 to a trough of $2.3801, indicating an +273.35% surge from the present price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.0776 | $3.0376 | $4.1618 | +123.02% |
| February, 2026 | $3.2293 | $2.6789 | $3.5379 | +134.01% |
| March, 2026 | $3.961 | $2.3801 | $6.7904 | +187.03% |
| April, 2026 | $3.4731 | $2.7214 | $4.1026 | +151.67% |
| May, 2026 | $2.8747 | $2.6947 | $3.7735 | +108.31% |
| June, 2026 | $2.9264 | $2.8356 | $3.155 | +112.06% |
| July, 2026 | $3.2285 | $2.6968 | $3.3385 | +133.95% |
| August, 2026 | $3.3302 | $3.1189 | $3.8057 | +141.32% |
| September, 2026 | $4.6222 | $3.2006 | $5.0172 | +234.95% |
| October, 2026 | $5.8939 | $4.3227 | $6.1639 | +327.10% |
| November, 2026 | $5.7256 | $5.5756 | $7.9243 | +314.90% |
| December, 2026 | $6.1677 | $5.366 | $6.9568 | +346.93% |
Tscan Therapeutics Inc Stock (TCRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Tscan Therapeutics Inc (TCRX) is $7.2809, with a high forecast of $10.80 and a low forecast of $3.7659. This indicates an +427.60% increase from the last price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.5894 | $5.4181 | $6.9794 | +377.49% |
| February, 2027 | $7.981 | $6.2198 | $8.6502 | +478.33% |
| March, 2027 | $7.8731 | $7.1814 | $9.7827 | +470.52% |
| April, 2027 | $8.5048 | $7.3639 | $8.9035 | +516.29% |
| May, 2027 | $10.07 | $7.60 | $10.08 | +629.83% |
| June, 2027 | $10.09 | $7.6134 | $10.80 | +630.86% |
| July, 2027 | $9.1092 | $9.0792 | $10.75 | +560.09% |
| August, 2027 | $6.3125 | $5.9825 | $9.14 | +357.43% |
| September, 2027 | $6.3067 | $5.6351 | $6.9034 | +357.01% |
| October, 2027 | $6.4301 | $5.9601 | $7.0561 | +365.95% |
| November, 2027 | $5.4634 | $5.0634 | $6.4959 | +295.90% |
| December, 2027 | $3.7676 | $3.7659 | $5.3542 | +173.01% |
Tscan Therapeutics Inc Stock (TCRX) Price Forecast for 2028
In 2028, Tscan Therapeutics Inc (TCRX) is projected to reach an average price of $4.4981, with a high projection of $6.0426 and a low estimate of $2.9535. This indicates an +225.95% rise from the last price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.2709 | $3.1209 | $4.2634 | +137.02% |
| February, 2028 | $4.6743 | $3.0718 | $5.2126 | +238.72% |
| March, 2028 | $4.6235 | $4.2097 | $5.0459 | +235.03% |
| April, 2028 | $4.8318 | $4.4994 | $5.2818 | +250.13% |
| May, 2028 | $4.476 | $4.106 | $6.0426 | +224.35% |
| June, 2028 | $4.4093 | $4.1676 | $5.7485 | +219.52% |
| July, 2028 | $4.4927 | $4.1102 | $4.976 | +225.56% |
| August, 2028 | $4.2568 | $3.9968 | $5.1435 | +208.47% |
| September, 2028 | $3.7585 | $3.5694 | $4.3876 | +172.35% |
| October, 2028 | $3.0535 | $2.9535 | $3.941 | +121.27% |
| November, 2028 | $3.3277 | $3.1044 | $4.1769 | +141.14% |
| December, 2028 | $4.5011 | $3.1948 | $4.7911 | +226.16% |
Tscan Therapeutics Inc Stock (TCRX) Price Forecast for 2029
The 2029 price forecast for Tscan Therapeutics Inc Stock (TCRX) is $5.9195 on average, with a high prediction of $8.6987 and a low estimate of $3.1402. This represents an +328.95% increase from the previous price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.8352 | $3.7952 | $4.9186 | +177.92% |
| February, 2029 | $3.9886 | $3.4377 | $4.296 | +189.03% |
| March, 2029 | $4.7219 | $3.1402 | $7.551 | +242.17% |
| April, 2029 | $4.3944 | $3.4828 | $4.8653 | +218.43% |
| May, 2029 | $3.6394 | $3.4594 | $4.5591 | +163.73% |
| June, 2029 | $3.6928 | $3.6011 | $3.9202 | +167.59% |
| July, 2029 | $3.9161 | $3.4636 | $4.0661 | +183.78% |
| August, 2029 | $4.1003 | $3.8761 | $4.5755 | +197.12% |
| September, 2029 | $4.9437 | $3.9711 | $5.4328 | +258.24% |
| October, 2029 | $6.6678 | $4.9445 | $6.9378 | +383.18% |
| November, 2029 | $6.5012 | $6.3512 | $8.6987 | +371.10% |
| December, 2029 | $7.5545 | $6.142 | $7.7337 | +447.43% |
Tscan Therapeutics Inc Stock (TCRX) Price Forecast for 2030
Tscan Therapeutics Inc Stock (TCRX) is expected to reach an average price of $8.2304 in 2030, with a high forecast of $11.52 and a low forecast of $4.942. This signifies an +496.40% surge from the last price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.3687 | $6.1962 | $7.7587 | +433.96% |
| February, 2030 | $8.762 | $6.9995 | $9.4304 | +534.93% |
| March, 2030 | $9.5054 | $7.9629 | $10.57 | +588.80% |
| April, 2030 | $8.8887 | $8.1479 | $9.7212 | +544.11% |
| May, 2030 | $10.79 | $8.32 | $10.80 | +682.07% |
| June, 2030 | $10.72 | $8.3351 | $11.46 | +676.63% |
| July, 2030 | $9.8338 | $9.8038 | $11.52 | +612.59% |
| August, 2030 | $7.0388 | $6.7088 | $9.865 | +410.06% |
| September, 2030 | $6.7938 | $6.3622 | $7.6301 | +392.31% |
| October, 2030 | $7.1601 | $6.5152 | $7.7857 | +418.85% |
| November, 2030 | $6.1951 | $5.7951 | $7.2263 | +348.92% |
| December, 2030 | $5.0901 | $4.942 | $6.0864 | +268.85% |
17.27%
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):